Cargando…

Prognostic Value and Genome Signature of m6A/m5C Regulated Genes in Early-Stage Lung Adenocarcinoma

RNA modifications implicate pathological and prognosis significance in cancer development and progression, of which, m6A and m5C are representative regulators. These RNA modifications could produce effects on the function of other RNA by regulating gene expression. Thus, in this study, we aimed to e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tian, Long, Wang, Yan, Tian, Jie, Song, Wenpeng, Li, Lu, Che, Guowei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095361/ https://www.ncbi.nlm.nih.gov/pubmed/37047493 http://dx.doi.org/10.3390/ijms24076520

Ejemplares similares

Four m6A RNA Methylation Gene Signatures and Their Prognostic Values in Lung Adenocarcinoma
por: Wang, Yuzhu, et al.
Publicado: (2022)

Identification of the Signature Associated With m(6)A RNA Methylation Regulators and m(6)A-Related Genes and Construction of the Risk Score for Prognostication in Early-Stage Lung Adenocarcinoma
por: Guo, Bingzhou, et al.
Publicado: (2021)

An integrated analysis of prognostic mRNA signature in early- and progressive-stage gastric adenocarcinoma
por: Hong, Xiaoling, et al.
Publicado: (2023)

5-mRNA-based prognostic signature of survival in lung adenocarcinoma
por: Xia, Qian-Lin, et al.
Publicado: (2023)

Development and validation of a m(6)A -regulated prognostic signature in lung adenocarcinoma
por: Chen, Yaxin, et al.
Publicado: (2022)

Expression Status and Prognostic Value of m(6)A RNA Methylation Regulators in Lung Adenocarcinoma
por: Li, Xiuhong, et al.
Publicado: (2021)

Prognostic Value of Genomic Instability of m(6)A-Related lncRNAs in Lung Adenocarcinoma
por: Li, Rui, et al.
Publicado: (2022)

Corrigendum: Development and validation of a m(6)A -regulated prognostic signature in lung adenocarcinoma
por: Chen, Yaxin, et al.
Publicado: (2023)

Prognostic and predictive value of radiomic signature in stage I lung adenocarcinomas following complete lobectomy
por: Nie, Wei, et al.
Publicado: (2022)

Prognostic value of IL-6R mRNA in lung adenocarcinoma and squamous cell carcinoma
por: Xu, Bin, et al.
Publicado: (2018)

Integrated Analysis to Evaluate the Prognostic Value of Signature mRNAs in Glioblastoma Multiforme
por: Yang, Ji’an, et al.
Publicado: (2020)

A robust prognostic gene expression signature for early stage lung adenocarcinoma
por: Krzystanek, Marcin, et al.
Publicado: (2016)

The genomic and transcriptome characteristics of lung adenocarcinoma patients with previous breast cancer
por: Wang, Yan, et al.
Publicado: (2022)

The prognostic value and mechanisms of centromere protein M in patients with lung adenocarcinoma
por: Qi, Ning, et al.
Publicado: (2022)

A five-m6A regulatory gene signature is a prognostic biomarker in lung adenocarcinoma patients
por: Wu, Xiao, et al.
Publicado: (2021)

A Distinct Glucose Metabolism Signature of Lung Adenocarcinoma With Prognostic Value
por: Li, Ding, et al.
Publicado: (2022)

Gene Signatures and Prognostic Values of m6A RNA Methylation Regulators in Ovarian Cancer
por: Han, Xiao, et al.
Publicado: (2020)

Gene Signatures and Prognostic Values of m6A Regulators in Hepatocellular Carcinoma
por: Wang, Pei, et al.
Publicado: (2020)

Gene Signatures and Prognostic Values of m(6)A Genes in Nasopharyngeal Carcinoma
por: Lu, Shanshan, et al.
Publicado: (2020)

The Prognostic Value of m6A RNA Methylation Regulators in Colon Adenocarcinoma
por: Liu, Tao, et al.
Publicado: (2019)

Prognostic value of minichromosome maintenance mRNA expression in early-stage pancreatic ductal adenocarcinoma patients after pancreaticoduodenectomy
por: Liao, Xiwen, et al.
Publicado: (2018)

Development and validation of m6A RNA methylation regulators-based signature in lung adenocarcinoma
por: Guo, Wei, et al.
Publicado: (2021)

Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma
por: Wu, Pancheng, et al.
Publicado: (2020)

Identification of an Individualized Metabolism Prognostic Signature and Related Therapy Regimens in Early Stage Lung Adenocarcinoma
por: Hu, Junjie, et al.
Publicado: (2021)

Potential Prognostic Value of a Seven m6A-Related LncRNAs Signature and the Correlative Immune Infiltration in Colon Adenocarcinoma
por: Chai, Xiu-kun, et al.
Publicado: (2021)

m7G-Associated subtypes, tumor microenvironment, and validation of prognostic signature in lung adenocarcinoma
por: Wang, Guangyao, et al.
Publicado: (2022)

Expression and Prognostic Significance of m6A-Related Genes in Lung Adenocarcinoma
por: Zhang, Yingying, et al.
Publicado: (2020)

The prognostic value and immune landscaps of m6A/m5C-related lncRNAs signature in the low grade glioma
por: Li, Ran, et al.
Publicado: (2023)

Diagnostic and prognostic values of integrin α subfamily mRNA expression in colon adenocarcinoma
por: Gong, Yi-Zhen, et al.
Publicado: (2019)

m6A RNA Methylation Regulators Participate in the Malignant Progression and Have Clinical Prognostic Value in Lung Adenocarcinoma
por: Li, Fangwei, et al.
Publicado: (2020)

The prognostic value of serum albumin–globulin ratio in early-stage non-small cell lung cancer: a retrospective study
por: Wang, Yan, et al.
Publicado: (2019)

Prognostic and Predictive Value of Three DNA Methylation Signatures in Lung Adenocarcinoma
por: Wang, Yanfang, et al.
Publicado: (2019)

Prognostic Fifteen-Gene Signature for Early Stage Pancreatic Ductal Adenocarcinoma
por: Chen, Dung-Tsa, et al.
Publicado: (2015)

The Perspective of Diagnostic and Prognostic Values of Lipoxygenases mRNA Expression in Colon Adenocarcinoma
por: Ruan, Guo-Tian, et al.
Publicado: (2020)

Prognostic Value of Tumor Budding in Early-Stage Cervical Adenocarcinomas
por: Satabongkoch, Nopporn, et al.
Publicado: (2017)

A Prognostic Signature for Colon Adenocarcinoma Patients Based on m6A-Related lncRNAs
por: Zhou, Su-Zhe, et al.
Publicado: (2023)

Ferroptosis Characterization in Lung Adenocarcinomas Reveals Prognostic Signature With Immunotherapeutic Implication
por: Sun, Sijin, et al.
Publicado: (2021)

Prognostic and Predictive Value of m6A “Eraser” Related Gene Signature in Gastric Cancer
por: Xu, Xin, et al.
Publicado: (2021)

Prognostic value of consolidation-to-tumor ratio on computed tomography in NSCLC: a meta-analysis
por: Wu, Yongming, et al.
Publicado: (2023)

Screening and identifying a novel M-MDSCs-related gene signature for predicting prognostic risk and immunotherapeutic responses in patients with lung adenocarcinoma
por: Wang, Geng-Chong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6vd4o9pj7ghngha1990quptdlg